Now that the data is going to a 23andMe-adjacent nonprofit, which is also making similar promises, I guess nothing much has ...

Me Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research Institute, a California-based nonprofit led by company co-founder and ...

Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

At the time of its bid, Regeneron said it would "prioritize the privacy, security and ethical use of 23andMe's customer data." But lawmakers voiced concern that no matter who the buyer is, the ...

Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company's privacy policies. Regeneron, a biotech company, ...

Its co-founder and CEO Anne Wojcicki also resigned from the top post, but remained as a board member. Also see: 23andMe users alerted they may want to delete genetic data. Here’s how to do it ...

Biotech company Regeneron buying 23andMe for $256 million Regeneron said Monday that it will comply with 23andMe’s privacy policies and applicable law regarding all client data.

Regeneron will be keeping all of 23andMe’s employees, Jensen added. As part of the court-supervised sale process, 23andMe required all bidders to guarantee that they will comply with its privacy ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.